Triferic AVNU — Competitive Intelligence Brief

Triferic AVNU (Triferic AVNU) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Iron replacement agent. Area: Nephrology / Hematology.

marketed Iron replacement agent Iron (Fe3+) delivery system Nephrology / Hematology Small molecule

Target snapshot

Triferic AVNU (Triferic AVNU) — Rockwell Medical Technologies, Inc.. Triferic AVNU is an iron replacement therapy that delivers iron directly into the bloodstream during hemodialysis to treat iron deficiency anemia.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Triferic AVNU TARGET	Triferic AVNU	Rockwell Medical Technologies, Inc.	marketed	Iron replacement agent	Iron (Fe3+) delivery system
Aggressive iron dextran supplementation	Aggressive iron dextran supplementation	Shanghai East Hospital	marketed	Iron replacement agent	Iron (Fe3+) for hemoglobin and myoglobin synthesis
intravenous iron carboxymaltose	intravenous iron carboxymaltose	University of Zurich	marketed	Intravenous iron replacement agent	Iron (Fe³⁺) delivery system; transferrin receptor-mediated uptake
Iron isomaltoside	Iron isomaltoside	Thomas Jefferson University	marketed	Iron replacement agent	Iron (Fe3+) / transferrin receptor
Iron Carboxymaltose	Iron Carboxymaltose	Albina Nowak, MD	marketed	Intravenous iron replacement agent	Iron(III) ion; transferrin and ferritin (iron-binding proteins)
ferric(III)carboxymaltose	ferric(III)carboxymaltose	Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)	marketed	Iron replacement agent	Iron metabolism / transferrin-mediated iron transport
Intravenous iron sucrose	Intravenous iron sucrose	Ain Shams University	marketed	Iron replacement agent

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Iron replacement agent class)

1. University of Maryland, Baltimore · 2 drugs in this class
2. Ain Shams University · 1 drug in this class
3. American Regent, Inc. · 1 drug in this class
4. Azad Pharma AG · 1 drug in this class
5. CN NGANOU-GNINDJIO, MD, MSc · 1 drug in this class
6. China-Japan Friendship Hospital · 1 drug in this class
7. Hallym University Medical Center · 1 drug in this class
8. J. Uriach and Company · 1 drug in this class
9. JW Pharmaceutical · 1 drug in this class
10. Prince of Wales Hospital, Shatin, Hong Kong · 1 drug in this class